Hyderabad grapples with black marketing of critical drugs – Times of India – 9 July 2020

Much like other metro cities, Hyderabad too is reeling under a severe shortage of Remdesivir and Tocilizumab two critical drugs being used for treatment of Covid-19 patients.

Although six Indian companies recently got permit from the parent American company Gilead Sciences to manufacture and sell the generic version of Remdesivir in India, there is still an acute shortage of both these drugs in all metropolitan cities, including Hyderabad – Dr P Raghu Ram, president, Association of Surgeons of India.

Click here to read full article